Potent anti-edematous and protective effects of ciprofloxacin in pulmonary ricinosis
The plant-toxin ricin, is considered a biological threat agent of concern and is most toxic when inhaled. Pulmonary exposure to a lethal dose of ricin can be redressed by treatment with anti-ricin antibodies, however late antitoxin intervention is of limited efficacy. This limitation is associated with the overt lung damage, clinically manifested as severe pulmonary inflammation, which develops over time. Increased evidence indicates that ciprofloxacin, a broad spectrum anti-microbial agent, possesses immunomodulatory properties. Here we demonstrate, that while anti-ricin antibody administration at late hours after intranasal exposure to ricin confers limited protection to mice, highly efficient protection can be achieved by adding ciprofloxacin to the antibody treatment. We further demonstrate that parameters associated with lung injury, in particular pulmonary pro-inflammatory cytokine production, neutrophil migration and edema, are sharply reduced in ricin-intoxicated mice that were treated with ciprofloxacin. Presented data highlights the potential clinical application of ciprofloxacin as a beneficial immunomodulatory agent in the course of ricin intoxication.